The effectiveness and cost-effectiveness of hepatitis c screening for migrants in the EU/EEA: A systematic review
Greenaway, C., Makarenko, I., Chakra, C.N.A., Alabdulkarim, B., Christensen, R., Palayew, A., Tran, A., Staub, L., Pareek, M., Meerpohl, J.J., Noori, T., Veldhuijzen, I., Pottie, K., Castelli, F., Morton, R.L.
Communicable disease threats report Week 19, 5-11 May 2013
The ECDC communicable disease threats report is a weekly bulletin intended for epidemiologists and health professionals in the area of communicable disease prevention and control.
Risk assessment on change of testing requirements for partner donation of reproductive cells
In May 2011, the European Commission asked ECDC to estimate the change in total exposure risk to hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV) during reproductive cell handling and storage for secondary parties, if the current scheme of testing at each cell donation would change to testing partner donors of reproductive cells once or twice a year.